Top 25 Biotechs Of 2016
A year after biotech stocks began trending down, as investors retreated from the markets based on fears that public anger over rising drug costs would lead to price curbs imposed by Washington, the results can be seen in this year’s GEN list of Top 25 Biotech Companies.
The total market capitalization of the 25 companies on this year’s list has slid 14.5%, to 1.047 trillion, from $1.225 trillion last year. Yet this year’s total is still 5.6% above the combined $990.89 billion market cap of the Top 25 Biotech Companies of 2014, so investors who stuck out the volatile biotech market of the past year have something to show for their endurance.
The total market capitalization of the 25 companies on this year’s list has slid 14.5%, to 1.047 trillion, from $1.225 trillion last year. Yet this year’s total is still 5.6% above the combined $990.89 billion market cap of the Top 25 Biotech Companies of 2014, so investors who stuck out the volatile biotech market of the past year have something to show for their endurance.